Australia markets open in 25 minutes

Qualigen Therapeutics Inc (7R9.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.2520-0.0040 (-1.56%)
At close: 02:36PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
Cash flows from operating activities
Net income
-13,417
-13,417
-18,641
-17,897
Depreciation & amortisation
4.495
4.495
12.165
338.277
Stock-based compensation
1,099
1,099
4,765
5,294
Change in working capital
1,112
1,112
-642.866
2,213
Accounts receivable
-
-
417.708
41.25
Inventory
-
-
-637.41
111.422
Accounts payable
1,603
1,603
-43.44
385.455
Other working capital
-10,304
-10,304
-13,248
-14,872
Other non-cash items
2,547
2,547
-
101.75
Net cash provided by operating activities
-10,304
-10,304
-13,248
-14,731
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-319.117
-141.364
Net cash used for investing activities
4,216
4,216
-183.763
-141.364
Cash flows from financing activities
Debt repayment
-550
-550
0
-138.739
Common stock issued
-
-
0
8,820
Common stock repurchased
0
0
-0.505
0
Other financing activities
-
-
-
-706.929
Net cash used provided by (used for) financing activities
-550
-550
2,911
8,434
Net change in cash
-6,638
-6,638
-10,521
-6,438
Cash at beginning of period
7,040
7,040
17,538
23,977
Cash at end of period
401.803
401.803
3,166
17,538
Free cash flow
Operating cash flow
-10,304
-10,304
-13,248
-14,731
Capital expenditure
-
-
-319.117
-141.364
Free cash flow
-10,304
-10,304
-13,248
-14,872